![]() |
Trials |
Phase I Study of Single Agent MK-3475 in Patients With Progressive Locally Advanced or Metastatic Carcinoma, Melanoma, and Non-Small Cell Lung CarcinomaCancer type: Lung cancer Phase: I Principal Investigator: Fløtten Øystein Country: NO Keywords: Norway, Bergen Status: Inclusion completed Link to Clinicaltrials.gov: http://clinicaltrials.gov/ct2/show/NCT01295827 |